Table 4 Median time of response in ALK-rearranged adenocarcinoma patients treated with crizotinib
From: ALK-rearranged pulmonary adenocarcinoma in Thai Patients: From diagnosis to treatment efficacy
Treatment line | Time of response, montha, range (median) |
|---|---|
First-line (N = 4) | 2–16 (5.5) |
Second-line (N = 4) | 3–13 (5.5) |
Third- and fourth-line (N = 6) | 1–10 (8) |